Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners

Abstract

Covering: 2011 to 2021

The structural division of ansamycins, including those of atypical cores and different lengths of the ansa chains, is presented. Recently discovered benzenoid and atypical ansamycin scaffolds are presented in relation to their natural source and biosynthetic routes realized in bacteria as well as their muta and semisynthetic modifications influencing biological properties. To better understand the structure–activity relationships among benzenoid ansamycins structural aspects together with mechanisms of action regarding different targets in cells, are discussed. The most promising directions for structural optimizations of benzenoid ansamycins, characterized by predominant anticancer properties, were discussed in view of their potential medical and pharmaceutical applications. The bibliography of the review covers mainly years from 2011 to 2021.

Graphical abstract: Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners

Article information

Article type
Review Article
Submitted
18 Jan 2022
First published
09 Mar 2022
This article is Open Access
Creative Commons BY license

Nat. Prod. Rep., 2022, Advance Article

Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners

N. Skrzypczak and P. Przybylski, Nat. Prod. Rep., 2022, Advance Article , DOI: 10.1039/D2NP00004K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements